BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31120217)

  • 1. [Hydrochlorothiazide and skin cancer].
    Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Brief: Hydrochlorothiazide and skin cancer.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
    Garrido PM; Borges-Costa J
    Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
    Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
    Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
    J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis.
    Heisel AGU; Vuurboom MD; Daams JG; de Rie MA; Vogt L; van den Born BH; Olde Engberink RHG
    Vascul Pharmacol; 2023 Jun; 150():107173. PubMed ID: 37084802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
    Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
    Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydrochlorothiazide and skin cancer].
    Schmutz JL
    Ann Dermatol Venereol; 2018 Mar; 145(3):225-226. PubMed ID: 29398068
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
    Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
    Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
    Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
    Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
    Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
    Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antihypertensive drugs and risk of skin cancer.
    Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
    Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
    J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer.
    Kreutz R; Algharably EAH; Douros A
    J Hypertens; 2019 Oct; 37(10):1950-1958. PubMed ID: 31145177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population.
    Tiba APL; Cury-Martins J; Miyashiro DR; Sanches JA
    Int J Dermatol; 2022 Jun; 61(6):e213-e214. PubMed ID: 34480765
    [No Abstract]   [Full Text] [Related]  

  • 16. Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature.
    Tchernev G; Patterson JW
    Expert Rev Clin Pharmacol; 2021 Mar; 14(3):289-293. PubMed ID: 33576302
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
    Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
    Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
    Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
    J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of diuretic therapy and reconsideration for aldosterone receptors blockers.
    Armanini D; Fiore C
    Hypertension; 2010 Jan; 55(1):e5. PubMed ID: 19948981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.